Medication reference
Ampicillin
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Ampicillin (opens in a new tab)Original source URL: https://globalrph.com/dilution/ampicillin/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/ampicillin/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:45:58.048904+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- 8fe4c96a272c7e280b898aa50d135b23c174fe0e545741c818f76d9850e9e500
- Original response SHA-256
- 59d9748ac258dd112d46d11687deae375814336bd296b267ded55cf3b50d63d9
- Source body SHA-256
- ba7393e444bbc95d318007566df5471a2620c7ca607bed92d88fee33799ee67f
AMPICILLIN |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Usual Diluents |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| [0 - 1 gram/ 50 ml] [30 minutes] [Over 1 gram/ 100 ml] [30 minutes] |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stability / Miscellaneous |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Label: REFRIGERATE.
DIRECTIONS FOR USE For Intramuscular Use - Dissolve contents of a vial with the amount of Sterile Water for Injection, USP, or Bacteriostatic Water for Injection, USP, listed in the table below:
While Ampicillin for Injection, USP, 1 g and 2 g, are primarily for intravenous use, they may be administered intramusculary when the 250 mg or 500 mg vials are unavailable. In such instances, dissolve in 3.5 or 6.8 mL Sterile Water for Injection, USP, or Bacteriostatic Water for Injection, USP, respectively. The resulting solution will provide a concentration of 250 mg per mL. Ampicillin for Injection, USP, 125 mg, is intended primarily for pediatric use. It also serves as a convenient dosage form when small parenteral doses of the antibiotic are required. For Direct Intravenous Use - Add 5 mL Sterile Water for Injection, USP, or Bacteriostatic Water for Injection, USP to the 125, 250, and 500 mg vials and administer slowly over a 3- to 5- minute period. Ampicillin for Injection, USP, 1 g or 2 g, may also be given by direct Intravenous administration. Dissolve in 7.4 or 14.8 mL Sterile Water for Injection, USP, or Bacteriostatic Water for Injection, USP, respectively, and administer slowly over at least 10 to 15 minutes. CAUTION: More rapid administration may result in convulsive seizures. For Administration by Intravenous Drip - Reconstitute as directed above ( For Direct Intravenous Use) prior to diluting with Intravenous Solution. Stability studies on ampicillin sodium at several concentrations in various intravenous solutions indicate the drug will lose less than 10% activitiy at the temperatures noted for the time periods stated.
Only those solutions listed above should be used for the intravenous infusion of Ampicillin for injection, USP. The concentrations should fall within the range specified. The drug concentration and the rate and volume of the infusion should be adjusted so that the total dose of ampicillin is administered before the drug loses its stability in the solution in use. Pharmacy Bulk Package- This glass vial contains 10 grams ampicillin and is designed for use in the pharmacy in preparing IV additives. Add 94 mL Sterile Water for Injection, USP. The resulting solution will contain 100 milligrams ampicillin activity per mL, and is stable up to one hour at room temperature. Diluting further within one hour from 5 mg to 10 mg per mL, the resulting solution will remain stable for 8 hours at room temperature or 72 hours under refrigeration. DOSAGE AND ADMINISTRATION Patients weighing less than 40 kg (88 lbs): 25 to 50 mg/kg/day in equally divided doses at 6- to 8- hour intervals. Infections of the gastrointestinal and genitourinary tracts (including those caused by Neisseria gonorrhoeae in females). Patients weighing less than 40 kg (88 lbs): 50 mg/kg/day in equally divided doses at 6- to 8- hour intervals. In the treatment of chronic urinary tract and intestinal infections, frequent bacteriological and clinical appraisal is necessary. Smaller doses than those recommended above should not be used. Higher doses should be used for stubborn or severe infections. In stubborn infections, therapy may be required for several weeks. It may be necessary to continue clinical and/or bacteriological follow-up for several months after cessation of therapy. Urethritis in males due to N. gonorrhoeae. In the treatment of complications of gonorrheal urethritis, such as prostatitis and epididymitis, prolonged and intensive therapy is recommended. Cases of gonorrhea with a suspected primary lesion of syphilis should have darkfield examinations before receiving treatment. In all other cases where concomitant syphilis is suspected, monthly serological tests should be made for a minimum of four months. The doses for the preceding infections may be given by either the intramuscular or intravenous route. A change to oral ampicillin may be made when appropriate. Bacterial Meningitis Septicemia Treatment of all infections should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of bacterial eradication has been obtained. A minimum of 10-days treatment is recommended for any infection caused by Group A beta-hemolytic streptococci to help prevent the occurrence of acute rheumatic fever or acute glomerulonephritis. HOW SUPPLIED NDC 0781-3400-95 125 mg vial packaged in 10s Manufactured by |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- adjustment_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- class_level
- Provenance classification
- historical_class_level
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- ampicillin
Source ID
H51-E4257EE0B45BB58096BCEA97 - Generic name
- Ampicillin
Source ID
H51-B866B050545AA025A7418961 - Class
- Antibacterial
Source ID
H51-5038666F3717755F8BACD101 - Subclass
- Aminopenicillin
Source ID
H51-3D58AF450601C8846488D9F6 - Primary uses
- Susceptible enterococcal, streptococcal, Listeria, and other infections
Source ID
H51-838B4C631B4DE1FA9D40B002
- Susceptible enterococcal, streptococcal, Listeria, and other infections
- Mechanism
- Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis.
Source ID
H51-B03AC3E45BB196263469BB0D - Mechanism level
- class_level
Source ID
H51-17437987EBCCCFB53DDFED3C - Basic dosing orientation
- Adult | Existing preparation record; use current package insert for indication-specific selection | Common dose 1 to 2 g | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric and neonatal | Existing preparation record; use current package insert for indication-specific selection | Weight-based dose; age and indication dependent | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion
Source ID
H51-89FE200643B07893DFBD7FDC - Administration orientation
- Infuse over 15 to 30 minutes
Source ID
H51-82224320885618538706284B - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
Source ID
H51-12220CA6B52CC3B8E607B643 - Key safety orientation
- High sodium load may matter with large daily doses.
Source ID
H51-3E8F12E82C5B90CA730531BB - Review renal function and indication-specific dosing.
Source ID
H51-B86D026F4FC251A04D7EE690
- High sodium load may matter with large daily doses.
- Coverage path
- structured_local_snapshot
Source ID
H51-AB24A9B92ECC8A5B0758C275 - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-318A74D16A9CBA5EACD1F8C1 - Legacy title
- Ampicillin
Source ID
H51-D0583A3FC1965B3FA533E141 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-0070D0CA9056D8F3119AD44D - Search text
- Ampicillin Antibacterial Aminopenicillin Susceptible enterococcal, streptococcal, Listeria, and other infections Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis. Adult | Existing preparation record; use current package insert for indication-specific selection | Common dose 1 to 2 g | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric and neonatal | Existing preparation record; use current package insert for indication-specific selection | Weight-based dose; age and indication dependent | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion Infuse over 15 to 30 minutes Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method. High sodium load may matter with large daily doses. Review renal function and indication-specific dosing. Structured GlobalRPh route snapshot
Source ID
H51-A995EFEFB2C53E28540BBE79 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ampicillin (opens in a new tab)
Source ID
H51-5BBA4BE04F40788E1E554E8A - Official access mode
- search
Source ID
H51-24B88DC984EA2F167B12737F - Official access url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Ampicillin (opens in a new tab)
Source ID
H51-0218D514A7BF02909A8F4EC7 - Official search query
- Ampicillin
Source ID
H51-74FC095C53B14F9E20B1C02F - Official access reason
- A source-backed DailyMed search is available; select and confirm the exact IV product.
Source ID
H51-C8AA1ABCF8CCD0D4D62B559E
No separate structured rows were bundled for IV push, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-7F45408441C53F7526F47638Source IDH51-3B98B8C61D27390D792B449D | Common dose 1 to 2 gSource IDH51-771EF63FF37FA051578B88DB | Reconstitute vial with Sterile Water for Injection as directed by vial strength.Source IDH51-506B81C5543C2CD778C32914 | NS preferred for many admixtures; confirm product-specific compatibilitySource IDH51-A5DFFE5A5C0D8FE64D9FAC16 | 50 to 100 mLSource IDH51-0C38D97EC1836C3781E268DD | Commonly 10 to 30 mg/mLSource IDH51-3E2C9BDC4B10A19C29E287EA | Infuse over 15 to 30 minutesSource IDH51-99FC2E572BD5E264B1D1A4F1 | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-AF2E06A033100215AEEF75EB | Use promptly after preparation; extended or continuous infusion requires validated stability data.Source IDH51-46FD953E7FFC48FF95C92975 |
Source IDH51-8D7695F88FD64090A795821ASource IDH51-75B43902791833AFA58D66FB | Weight-based dose; age and indication dependentSource IDH51-D7B4053C2D49FCAB2AF180CD | Reconstitute per vial labeling.Source IDH51-E779DCA93E7C55CD6B657376 | NS or compatible fluidSource IDH51-B0BDCC803FCE6008319A4E46 | Volume based on weight and fluid allowanceSource IDH51-668991A15B9092829FAAAA6A | Institution-specificSource IDH51-F29BA2C806630856DDD5A7C1 | Infuse over 15 to 30 minutesSource IDH51-DFDFAC2639E83444C77416B0 | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-812A535E9A9D4C88EB06DE25 | Meningitis and neonatal sepsis regimens use different dose and interval selections.Source IDH51-FDF39AC2590B759E6DA7812F |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-F25E9DD42291E69EC0E6DC55Source IDH51-3E1B95B32C22F8772D9F91DC | AdultSource IDH51-19C5AAFADC86746E649861E5 | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-80687F89C5621A2B21B6B96C | Common dose 1 to 2 gSource IDH51-9A764480CB757CE56A0D0CA1 | Not normalized in the preparation recordSource IDH51-8D0443EAAEED3BAFF75DE8CD | See current package insert and professional guidanceSource IDH51-7F593EABF0069F190145CA0F | Infuse over 15 to 30 minutesSource IDH51-DAF6810DCD5D97EF5F95B36F | Existing GlobalRPh structured preparation snapshotSource IDH51-B466D7FE7834FF3C8EAD8C32 | Use promptly after preparation; extended or continuous infusion requires validated stability data.Source IDH51-260022B7B4CE3713C37BB189 |
Source IDH51-F908383F871250FBD493DF30Source IDH51-F9235F43F48E898AB025C271 | Pediatric and neonatalSource IDH51-F565A2361DFA0062921A5A0A | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-1AA90C96E12E9C9EF9AEC0A4 | Weight-based dose; age and indication dependentSource IDH51-69214BF89A61566EE4F60658 | Not normalized in the preparation recordSource IDH51-003D971F304C3B9B72995E4A | See current package insert and professional guidanceSource IDH51-E39DAEEFFCA9D6D8B24606E7 | Infuse over 15 to 30 minutesSource IDH51-740DF8E98778F58F70D46EE0 | Existing GlobalRPh structured preparation snapshotSource IDH51-7C5E0F617E03C0E5D32E43C5 | Meningitis and neonatal sepsis regimens use different dose and interval selections.Source IDH51-1365EE46D96E9FF6409BE93E |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- adjustment_required
Source ID
H51-51C7D9528F6F51A97365BBA5 - Summary
- Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
Source ID
H51-FE843377EFB681B2AC8606D8 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-EAE147BEB9F25ACA74B89C3A
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Susceptible enterococcal, streptococcal, Listeria, and other infections
Source ID
H51-B4D6A8A984A30BDF985AAA94
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- High sodium load may matter with large daily doses.
Source ID
H51-064AFC8EE68FF3D89DA84F7D - Review renal function and indication-specific dosing.
Source ID
H51-51997B0E25D8DABB263119DE
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal function
Source ID
H51-4CA8262CFFB91EC69DDDC308 - CBC and hepatic tests during prolonged therapy
Source ID
H51-2B52E10CAF3FDEB1C42B9337 - Hypersensitivity
Source ID
H51-0A066E86E3C85FF1223FA345
Historical supplemental professional sources
Recovered v5.1 source content; historical, awaiting current review.
| Label | Url | Kind |
|---|---|---|
Source IDH51-A3FFEDC702231C94DC130D09Source IDH51-3D1F55805303A165886514AC | https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)Source IDH51-C8896D7E25BE4C6C1B52EF0C | Professional institutional guidanceSource IDH51-B10CCA416A16300876FA1D55 |
Source IDH51-C53835A307F5EFB521A13715Source IDH51-133D8A99FA0E192427C62DE2 | https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)Source IDH51-03035CE9AA07EC7D018256A7 | Professional institutional guidanceSource IDH51-B0879C36DFA13EC2A02C1582 |
Source IDH51-09A8B50504FB4DFD73330718Source IDH51-3F00EEB27396C9C83BD717FB | https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-C4005400833340D19CDB5770 | Professional institutional guidanceSource IDH51-F6A82A47E756FA8FC43328E9 |
Source IDH51-4F651A414564CEE1182FCD22Source IDH51-25C5C89C72EAF52E133B31EA | https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-B365EC7A33BF2EB40E47DD58 | Professional institutional guidanceSource IDH51-1F9ADA09E1038356578CF05F |
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
ampicillinSource ID
H51-0482EEA233C39EB48C0C6681Generic name
AmpicillinSource ID
H51-7B8D38BA13C4E7BD8991C062Brand names
- Omnipen
Source ID
H51-476184CE9B5F7F1AC3BE9CD5
Class
AntibacterialSource ID
H51-8C3DD026008290BCD4C4247DSubclass
AminopenicillinSource ID
H51-7301D448079008C612FF2E30Summary
Time-dependent beta-lactam with relatively short solution stability at higher concentrations and room temperature.Source ID
H51-42CE9E2A6774EFBAF695434BPopulations
- Adult
Source ID
H51-7351AAA41D175A14F7509409 - Pediatric
Source ID
H51-D1AC0E71CF5416D356F872CA - Neonatal
Source ID
H51-7078B6543079C0402838B875
Evidence tier
Core reference - verify current labelSource ID
H51-68EF6527FB0B67275C2BB317High alert
falseSource ID
H51-2E20D1A9D23BD4D53315ADBAHazardous
falseSource ID
H51-4AB7AC588A0696123B5067D3Status
ActiveSource ID
H51-0DC56A10ACB744DB617BAE4DReviewed
2026-08-29Source ID
H51-04D175ABBB800E1085E3F681Version added
1.0Source ID
H51-ACC3BCC7707B49F5E426CA4ESources
| Label | Url | Kind |
|---|---|---|
Source IDH51-EB591ED11868F8295B032565Source IDH51-05550B8089D402E529DFD0D6 | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ampicillin (opens in a new tab)Source IDH51-6839C4CE24EA613A9FF2AD5D | PrimarySource IDH51-5723616C2EDB6484E605974B |
Source IDH51-759F58BE1F1DECB99E8B8943Source IDH51-6CDA8AD049B8C639CF0F6803 | legacy:autoSource IDH51-7EB597FD4EAA816C9DDB601E | LegacySource IDH51-0DC7FCC720236733607C09D6 |
Legacy title
AmpicillinSource ID
H51-07BB906263A2E6178638F7F8Clinical release verification
- Audit version
- 3.4
Source ID
H51-5EADFFF55C30E0C0F0BA6891 - Audited on
- 2026-08-30
Source ID
H51-0796338BB3BB773F5CF73375 - Level
- amber
Source ID
H51-CA0129AF39B7C75B1F763115 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-F86837F814717FE29A22C4D9 - Exact current label candidate
- false
Source ID
H51-4C8797A99B41F47AC51953AB - Numeric support ratio
- 0
Source ID
H51-A90DE7167D8F78CE99891378 - Reference url count
- 5
Source ID
H51-931A2AECBDD0C2FF631B8533 - Broken reference count
- 0
Source ID
H51-2407296DED61080DDCD43EE4 - Point of use confirmation required
- true
Source ID
H51-6E084C2B4F29AACB610776CA - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-F3192D99F8D1CAD178805E18 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ampicillin (opens in a new tab)
Source ID
H51-62DE6CCE693C51342FD73872
Dosing source fields
Id
ampicillinSource ID
H51-B03C64B1AB9E0BAF885CFF36Generic name
AmpicillinSource ID
H51-A178C06BFA1AAF00E1C0E4FECoverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-C0B67ECD3C859F797EECF01BPackage insert
- Query name
- Ampicillin
Source ID
H51-CA1808AA5091CC0B001C3C47 - Product and route must match
- true
Source ID
H51-6603CB4D8943BE73E01EE479 - Live current label enabled
- false
Source ID
H51-9451AF4EF08E610AB7391ADA - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-E4B93637DE9A0B5AC419E9AF - Direct official label access enabled
- true
Source ID
H51-673EC49B1D7491C4A08504F5 - Outbound server request required
- false
Source ID
H51-ED1B7D19E7F27738E435C35B - Local summary status
- not_bundled
Source ID
H51-18C1F967CB763C4A49B43277
Clinical review
- Locally normalized
- false
Source ID
H51-E3CB311845EAD574BC2DDED5 - Reviewed
- 2026-08-29
Source ID
H51-A295C38F828C1C0B45B0D829 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-EAE8C30EF59266F0010B7316
Clinical release verification
- Audit version
- 3.4
Source ID
H51-39D8410C7974436EE5B02EC4 - Audited on
- 2026-08-30
Source ID
H51-B0EEFD425CA7B20CDA55E4DF - Level
- amber
Source ID
H51-07F843C6942D09092F7B4AF0 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-770FC9A59B1C82A039F943AF - Exact current label candidate
- false
Source ID
H51-D3D30D212E6A18D6A4D8DDDB - Numeric support ratio
- 0
Source ID
H51-C83738C5BA746A1C927AC81F - Reference url count
- 5
Source ID
H51-4710212563B5E290424E1BA1 - Broken reference count
- 0
Source ID
H51-2905B4D5877886083DFF1E50 - Point of use confirmation required
- true
Source ID
H51-03C374B61549973F08F0D6BC - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-500A2054C17AB17673882F2B - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ampicillin (opens in a new tab)
Source ID
H51-0B372A3B70CCD2191532EA24
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- ampicillin
Source ID
H51-3048CBAA043485D2C34C0BFD - Name
- Ampicillin
Source ID
H51-00686E4919D98DE13087DA6D - Brands
- Omnipen
Source ID
H51-7E434E5052F9460192805F6B - Therapeutic class
- Antibacterial
Source ID
H51-FC520474BD1E4A01A414C4B9 - Review version
- 3.1
Source ID
H51-1FAA96F1D30E76540F6EF653 - Review date
- 2026-08-30
Source ID
H51-AAAD6BB72EEEC16D74AE346C - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-93978A5B1B651EE7C50BFF27 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-D9AB1DB6E4168F14E2EB04BF - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-85398162E2FFEE2331AF2311
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-0491E169F103B5F21F80B232 - Reconstitution concentration
- Reconstitute vial with Sterile Water for Injection as directed by vial strength. Reconstitute per vial labeling.
Source ID
H51-C7BF7D4D445866A267E1ED0E - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-6C20787EC005FD8B6B919506 - Appropriate standardized containers
- 50 to 100 mL Volume based on weight and fluid allowance
Source ID
H51-C56AD4A3FDCCA7D211956E11 - Adult dosing range
- Common dose 1 to 2 g Weight-based dose; age and indication dependent
Source ID
H51-E943F09A1F0A033EE2C13D03 - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-4E4A985354D3435335B54818 - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-6E2E5BF2A8794B499340F63D - Infusion time
- Infuse over 15 to 30 minutes
Source ID
H51-DE8EF985D6B2E1E86E68EC9F - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-E1A09835CAB7D83AFD316DE1 - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-C8F81046E61F6F12907A7624 - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ampicillin (opens in a new tab)
Source ID
H51-F34DEEE44CB5B834721A86E9
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-72879E75D13090F040E70053
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-A8D7E8F8F008134D5946FC49
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-CF9013A510533FD757DAC2A0
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-27D807BCBD94424C00E8F1D2
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-67777EB6FFB899F5AF8F6F62
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-1CD110654DEFEE0AEA7F2C57
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-9BB0809CC4310EEC14763460
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-0B203C152EE3BBF57947F293
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-5E4FA8B9F19B60F0BBD17C61
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-D1AE1D127F73A9AA5AE3F2E2
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-FE4F8C420FE32912986811B3 - Guide generation allowed
- true
Source ID
H51-0E33D6A24A91418617E048A9
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-7DC9C1648726EA8BFD99EFB5 - Guide generation allowed
- false
Source ID
H51-DA01AF71988030DF65029F18
- Neonatal
- Applicability
- supported_or_source_present
Source ID
H51-FBFE8F0194C3A0330EACFF54 - Guide generation allowed
- false
Source ID
H51-93809DEDB86714E84C8821FD
- Route presence
- Structured dilution
- true
Source ID
H51-9291A2254F82BD4189D6D66C - Iv push
- false
Source ID
H51-EE151CB4C2685E038E4C4226 - Continuous infusion
- true
Source ID
H51-CAEAECFBD406435949758E7D - Pediatric source
- true
Source ID
H51-C7055CC4452635DAD7C9F10E - Neonatal source
- true
Source ID
H51-DF8C5E8B0A6B9DED32930207
- Legacy reference
- Status
- not_available
Source ID
H51-D88E7D00DAFDB162C5B6653D
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-08FDDE5498D2820C54EF65DB
- Source files
- catalog.json
Source ID
H51-3F20E5C33D4814BED26265E9 - dosing.json
Source ID
H51-6911C463AFC5E534653D2477 - legacy-map.json
Source ID
H51-DEFFE50BDCA1405B2340B497
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-993DC7F2F006C69B8A37A0B2
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-0482EEA233C39EB48C0C6681 | catalog.json/records/19/id | Historical; current review incomplete |
H51-7B8D38BA13C4E7BD8991C062 | catalog.json/records/19/generic_name | Historical; current review incomplete |
H51-476184CE9B5F7F1AC3BE9CD5 | catalog.json/records/19/brand_names/0 | Historical; current review incomplete |
H51-8C3DD026008290BCD4C4247D | catalog.json/records/19/class | Historical; current review incomplete |
H51-7301D448079008C612FF2E30 | catalog.json/records/19/subclass | Historical; current review incomplete |
H51-42CE9E2A6774EFBAF695434B | catalog.json/records/19/summary | Historical; current review incomplete |
H51-B4D6A8A984A30BDF985AAA94 | catalog.json/records/19/common_uses/0 | Historical; current review incomplete |
H51-7F45408441C53F7526F47638 | catalog.json/records/19/preparations/0 | Historical; current review incomplete |
H51-3B98B8C61D27390D792B449D | catalog.json/records/19/preparations/0/population | Historical; current review incomplete |
H51-771EF63FF37FA051578B88DB | catalog.json/records/19/preparations/0/amount | Historical; current review incomplete |
H51-506B81C5543C2CD778C32914 | catalog.json/records/19/preparations/0/reconstitution | Historical; current review incomplete |
H51-A5DFFE5A5C0D8FE64D9FAC16 | catalog.json/records/19/preparations/0/diluent | Historical; current review incomplete |
H51-0C38D97EC1836C3781E268DD | catalog.json/records/19/preparations/0/final_volume | Historical; current review incomplete |
H51-3E2C9BDC4B10A19C29E287EA | catalog.json/records/19/preparations/0/concentration | Historical; current review incomplete |
H51-99FC2E572BD5E264B1D1A4F1 | catalog.json/records/19/preparations/0/rate | Historical; current review incomplete |
H51-AF2E06A033100215AEEF75EB | catalog.json/records/19/preparations/0/stability | Historical; current review incomplete |
H51-46FD953E7FFC48FF95C92975 | catalog.json/records/19/preparations/0/notes | Historical; current review incomplete |
H51-8D7695F88FD64090A795821A | catalog.json/records/19/preparations/1 | Historical; current review incomplete |
H51-75B43902791833AFA58D66FB | catalog.json/records/19/preparations/1/population | Historical; current review incomplete |
H51-D7B4053C2D49FCAB2AF180CD | catalog.json/records/19/preparations/1/amount | Historical; current review incomplete |
H51-E779DCA93E7C55CD6B657376 | catalog.json/records/19/preparations/1/reconstitution | Historical; current review incomplete |
H51-B0BDCC803FCE6008319A4E46 | catalog.json/records/19/preparations/1/diluent | Historical; current review incomplete |
H51-668991A15B9092829FAAAA6A | catalog.json/records/19/preparations/1/final_volume | Historical; current review incomplete |
H51-F29BA2C806630856DDD5A7C1 | catalog.json/records/19/preparations/1/concentration | Historical; current review incomplete |
H51-DFDFAC2639E83444C77416B0 | catalog.json/records/19/preparations/1/rate | Historical; current review incomplete |
H51-812A535E9A9D4C88EB06DE25 | catalog.json/records/19/preparations/1/stability | Historical; current review incomplete |
H51-FDF39AC2590B759E6DA7812F | catalog.json/records/19/preparations/1/notes | Historical; current review incomplete |
H51-064AFC8EE68FF3D89DA84F7D | catalog.json/records/19/warnings/0 | Historical; current review incomplete |
H51-51997B0E25D8DABB263119DE | catalog.json/records/19/warnings/1 | Historical; current review incomplete |
H51-4CA8262CFFB91EC69DDDC308 | catalog.json/records/19/monitoring/0 | Historical; current review incomplete |
H51-2B52E10CAF3FDEB1C42B9337 | catalog.json/records/19/monitoring/1 | Historical; current review incomplete |
H51-0A066E86E3C85FF1223FA345 | catalog.json/records/19/monitoring/2 | Historical; current review incomplete |
H51-7351AAA41D175A14F7509409 | catalog.json/records/19/populations/0 | Historical; current review incomplete |
H51-D1AC0E71CF5416D356F872CA | catalog.json/records/19/populations/1 | Historical; current review incomplete |
H51-7078B6543079C0402838B875 | catalog.json/records/19/populations/2 | Historical; current review incomplete |
H51-68EF6527FB0B67275C2BB317 | catalog.json/records/19/evidence_tier | Historical; current review incomplete |
H51-2E20D1A9D23BD4D53315ADBA | catalog.json/records/19/high_alert | Historical; current review incomplete |
H51-4AB7AC588A0696123B5067D3 | catalog.json/records/19/hazardous | Historical; current review incomplete |
H51-0DC56A10ACB744DB617BAE4D | catalog.json/records/19/status | Historical; current review incomplete |
H51-04D175ABBB800E1085E3F681 | catalog.json/records/19/reviewed | Historical; current review incomplete |
H51-ACC3BCC7707B49F5E426CA4E | catalog.json/records/19/version_added | Historical; current review incomplete |
H51-EB591ED11868F8295B032565 | catalog.json/records/19/sources/0 | Historical; current review incomplete |
H51-05550B8089D402E529DFD0D6 | catalog.json/records/19/sources/0/label | Historical; current review incomplete |
H51-6839C4CE24EA613A9FF2AD5D | catalog.json/records/19/sources/0/url | Historical; current review incomplete |
H51-5723616C2EDB6484E605974B | catalog.json/records/19/sources/0/kind | Historical; current review incomplete |
H51-759F58BE1F1DECB99E8B8943 | catalog.json/records/19/sources/1 | Historical; current review incomplete |
H51-6CDA8AD049B8C639CF0F6803 | catalog.json/records/19/sources/1/label | Historical; current review incomplete |
H51-7EB597FD4EAA816C9DDB601E | catalog.json/records/19/sources/1/url | Historical; current review incomplete |
H51-0DC7FCC720236733607C09D6 | catalog.json/records/19/sources/1/kind | Historical; current review incomplete |
H51-07BB906263A2E6178638F7F8 | catalog.json/records/19/legacy_title | Historical; current review incomplete |
H51-5EADFFF55C30E0C0F0BA6891 | catalog.json/records/19/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-0796338BB3BB773F5CF73375 | catalog.json/records/19/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-CA0129AF39B7C75B1F763115 | catalog.json/records/19/clinical_release_verification/level | Historical; current review incomplete |
H51-F86837F814717FE29A22C4D9 | catalog.json/records/19/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-4C8797A99B41F47AC51953AB | catalog.json/records/19/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-C3D1185AFB1A1F809243B205 | catalog.json/records/19/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-FB82FD3E589C27A82FF6E30E | catalog.json/records/19/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-A90DE7167D8F78CE99891378 | catalog.json/records/19/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-931A2AECBDD0C2FF631B8533 | catalog.json/records/19/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-2407296DED61080DDCD43EE4 | catalog.json/records/19/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-6E084C2B4F29AACB610776CA | catalog.json/records/19/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-F3192D99F8D1CAD178805E18 | catalog.json/records/19/clinical_release_verification/note | Historical; current review incomplete |
H51-62DE6CCE693C51342FD73872 | catalog.json/records/19/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-B03C64B1AB9E0BAF885CFF36 | dosing.json/records/19/id | Historical; current review incomplete |
H51-A178C06BFA1AAF00E1C0E4FE | dosing.json/records/19/generic_name | Historical; current review incomplete |
H51-C0B67ECD3C859F797EECF01B | dosing.json/records/19/coverage_status | Historical; current review incomplete |
H51-CA1808AA5091CC0B001C3C47 | dosing.json/records/19/package_insert/query_name | Historical; current review incomplete |
H51-FD5C29CF06B492E082A4CA96 | dosing.json/records/19/package_insert/preferred_setid | Historical; current review incomplete |
H51-6603CB4D8943BE73E01EE479 | dosing.json/records/19/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-9451AF4EF08E610AB7391ADA | dosing.json/records/19/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-E4B93637DE9A0B5AC419E9AF | dosing.json/records/19/package_insert/source_priority | Historical; current review incomplete |
H51-673EC49B1D7491C4A08504F5 | dosing.json/records/19/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-ED1B7D19E7F27738E435C35B | dosing.json/records/19/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-18C1F967CB763C4A49B43277 | dosing.json/records/19/package_insert/local_summary_status | Historical; current review incomplete |
H51-51C7D9528F6F51A97365BBA5 | dosing.json/records/19/renal/classification | Historical; current review incomplete |
H51-FE843377EFB681B2AC8606D8 | dosing.json/records/19/renal/summary | Historical; current review incomplete |
H51-EAE147BEB9F25ACA74B89C3A | dosing.json/records/19/renal/method_note | Historical; current review incomplete |
H51-F25E9DD42291E69EC0E6DC55 | dosing.json/records/19/existing_route_snapshots/0 | Historical; current review incomplete |
H51-3E1B95B32C22F8772D9F91DC | dosing.json/records/19/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-19C5AAFADC86746E649861E5 | dosing.json/records/19/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-80687F89C5621A2B21B6B96C | dosing.json/records/19/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-9A764480CB757CE56A0D0CA1 | dosing.json/records/19/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-8D0443EAAEED3BAFF75DE8CD | dosing.json/records/19/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-7F593EABF0069F190145CA0F | dosing.json/records/19/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-DAF6810DCD5D97EF5F95B36F | dosing.json/records/19/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-B466D7FE7834FF3C8EAD8C32 | dosing.json/records/19/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-260022B7B4CE3713C37BB189 | dosing.json/records/19/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-F908383F871250FBD493DF30 | dosing.json/records/19/existing_route_snapshots/1 | Historical; current review incomplete |
H51-F9235F43F48E898AB025C271 | dosing.json/records/19/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-F565A2361DFA0062921A5A0A | dosing.json/records/19/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-1AA90C96E12E9C9EF9AEC0A4 | dosing.json/records/19/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-69214BF89A61566EE4F60658 | dosing.json/records/19/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-003D971F304C3B9B72995E4A | dosing.json/records/19/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-E39DAEEFFCA9D6D8B24606E7 | dosing.json/records/19/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-740DF8E98778F58F70D46EE0 | dosing.json/records/19/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-7C5E0F617E03C0E5D32E43C5 | dosing.json/records/19/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-1365EE46D96E9FF6409BE93E | dosing.json/records/19/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-A3FFEDC702231C94DC130D09 | dosing.json/records/19/professional_sources/0 | Historical; current review incomplete |
H51-3D1F55805303A165886514AC | dosing.json/records/19/professional_sources/0/label | Historical; current review incomplete |
H51-C8896D7E25BE4C6C1B52EF0C | dosing.json/records/19/professional_sources/0/url | Historical; current review incomplete |
H51-B10CCA416A16300876FA1D55 | dosing.json/records/19/professional_sources/0/kind | Historical; current review incomplete |
H51-C53835A307F5EFB521A13715 | dosing.json/records/19/professional_sources/1 | Historical; current review incomplete |
H51-133D8A99FA0E192427C62DE2 | dosing.json/records/19/professional_sources/1/label | Historical; current review incomplete |
H51-03035CE9AA07EC7D018256A7 | dosing.json/records/19/professional_sources/1/url | Historical; current review incomplete |
H51-B0879C36DFA13EC2A02C1582 | dosing.json/records/19/professional_sources/1/kind | Historical; current review incomplete |
H51-09A8B50504FB4DFD73330718 | dosing.json/records/19/professional_sources/2 | Historical; current review incomplete |
H51-3F00EEB27396C9C83BD717FB | dosing.json/records/19/professional_sources/2/label | Historical; current review incomplete |
H51-C4005400833340D19CDB5770 | dosing.json/records/19/professional_sources/2/url | Historical; current review incomplete |
H51-F6A82A47E756FA8FC43328E9 | dosing.json/records/19/professional_sources/2/kind | Historical; current review incomplete |
H51-4F651A414564CEE1182FCD22 | dosing.json/records/19/professional_sources/3 | Historical; current review incomplete |
H51-25C5C89C72EAF52E133B31EA | dosing.json/records/19/professional_sources/3/label | Historical; current review incomplete |
H51-B365EC7A33BF2EB40E47DD58 | dosing.json/records/19/professional_sources/3/url | Historical; current review incomplete |
H51-1F9ADA09E1038356578CF05F | dosing.json/records/19/professional_sources/3/kind | Historical; current review incomplete |
H51-E3CB311845EAD574BC2DDED5 | dosing.json/records/19/clinical_review/locally_normalized | Historical; current review incomplete |
H51-A295C38F828C1C0B45B0D829 | dosing.json/records/19/clinical_review/reviewed | Historical; current review incomplete |
H51-EAE8C30EF59266F0010B7316 | dosing.json/records/19/clinical_review/status | Historical; current review incomplete |
H51-39D8410C7974436EE5B02EC4 | dosing.json/records/19/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-B0EEFD425CA7B20CDA55E4DF | dosing.json/records/19/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-07F843C6942D09092F7B4AF0 | dosing.json/records/19/clinical_release_verification/level | Historical; current review incomplete |
H51-770FC9A59B1C82A039F943AF | dosing.json/records/19/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-D3D30D212E6A18D6A4D8DDDB | dosing.json/records/19/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-EBF2B0B6680B220190ADF0B1 | dosing.json/records/19/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-7A95CFEE8D49CF0C305ED88E | dosing.json/records/19/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-C83738C5BA746A1C927AC81F | dosing.json/records/19/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-4710212563B5E290424E1BA1 | dosing.json/records/19/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-2905B4D5877886083DFF1E50 | dosing.json/records/19/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-03C374B61549973F08F0D6BC | dosing.json/records/19/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-500A2054C17AB17673882F2B | dosing.json/records/19/clinical_release_verification/note | Historical; current review incomplete |
H51-0B372A3B70CCD2191532EA24 | dosing.json/records/19/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-E4257EE0B45BB58096BCEA97 | first-look-v5.1.json/records/19/id | Historical; current review incomplete |
H51-B866B050545AA025A7418961 | first-look-v5.1.json/records/19/generic_name | Historical; current review incomplete |
H51-5038666F3717755F8BACD101 | first-look-v5.1.json/records/19/class | Historical; current review incomplete |
H51-3D58AF450601C8846488D9F6 | first-look-v5.1.json/records/19/subclass | Historical; current review incomplete |
H51-838B4C631B4DE1FA9D40B002 | first-look-v5.1.json/records/19/primary_uses/0 | Historical; current review incomplete |
H51-B03AC3E45BB196263469BB0D | first-look-v5.1.json/records/19/mechanism | Historical; current review incomplete |
H51-17437987EBCCCFB53DDFED3C | first-look-v5.1.json/records/19/mechanism_level | Historical; current review incomplete |
H51-89FE200643B07893DFBD7FDC | first-look-v5.1.json/records/19/basic_dosing_orientation | Historical; current review incomplete |
H51-82224320885618538706284B | first-look-v5.1.json/records/19/administration_orientation | Historical; current review incomplete |
H51-12220CA6B52CC3B8E607B643 | first-look-v5.1.json/records/19/renal_and_population_orientation | Historical; current review incomplete |
H51-3E8F12E82C5B90CA730531BB | first-look-v5.1.json/records/19/key_safety_orientation/0 | Historical; current review incomplete |
H51-B86D026F4FC251A04D7EE690 | first-look-v5.1.json/records/19/key_safety_orientation/1 | Historical; current review incomplete |
H51-AB24A9B92ECC8A5B0758C275 | first-look-v5.1.json/records/19/coverage_path | Historical; current review incomplete |
H51-318A74D16A9CBA5EACD1F8C1 | first-look-v5.1.json/records/19/coverage_path_label | Historical; current review incomplete |
H51-5578DAC0E392C21C902AA547 | first-look-v5.1.json/records/19/official_label_url | Historical; current review incomplete |
H51-D0583A3FC1965B3FA533E141 | first-look-v5.1.json/records/19/legacy_title | Historical; current review incomplete |
H51-0070D0CA9056D8F3119AD44D | first-look-v5.1.json/records/19/review_note | Historical; current review incomplete |
H51-A995EFEFB2C53E28540BBE79 | first-look-v5.1.json/records/19/search_text | Historical; current review incomplete |
H51-5BBA4BE04F40788E1E554E8A | first-look-v5.1.json/records/19/official_search_url | Historical; current review incomplete |
H51-24B88DC984EA2F167B12737F | first-look-v5.1.json/records/19/official_access_mode | Historical; current review incomplete |
H51-0218D514A7BF02909A8F4EC7 | first-look-v5.1.json/records/19/official_access_url | Historical; current review incomplete |
H51-74FC095C53B14F9E20B1C02F | first-look-v5.1.json/records/19/official_search_query | Historical; current review incomplete |
H51-C8AA1ABCF8CCD0D4D62B559E | first-look-v5.1.json/records/19/official_access_reason | Historical; current review incomplete |
H51-3048CBAA043485D2C34C0BFD | preparation-assessments-v3.8.json/19/id | Historical; current review incomplete |
H51-00686E4919D98DE13087DA6D | preparation-assessments-v3.8.json/19/name | Historical; current review incomplete |
H51-7E434E5052F9460192805F6B | preparation-assessments-v3.8.json/19/brands | Historical; current review incomplete |
H51-FC520474BD1E4A01A414C4B9 | preparation-assessments-v3.8.json/19/therapeutic_class | Historical; current review incomplete |
H51-1FAA96F1D30E76540F6EF653 | preparation-assessments-v3.8.json/19/review_version | Historical; current review incomplete |
H51-AAAD6BB72EEEC16D74AE346C | preparation-assessments-v3.8.json/19/review_date | Historical; current review incomplete |
H51-93978A5B1B651EE7C50BFF27 | preparation-assessments-v3.8.json/19/release_status | Historical; current review incomplete |
H51-D9AB1DB6E4168F14E2EB04BF | preparation-assessments-v3.8.json/19/market_status/status | Historical; current review incomplete |
H51-85398162E2FFEE2331AF2311 | preparation-assessments-v3.8.json/19/market_status/basis | Historical; current review incomplete |
H51-0491E169F103B5F21F80B232 | preparation-assessments-v3.8.json/19/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-C7BF7D4D445866A267E1ED0E | preparation-assessments-v3.8.json/19/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-6C20787EC005FD8B6B919506 | preparation-assessments-v3.8.json/19/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-C56AD4A3FDCCA7D211956E11 | preparation-assessments-v3.8.json/19/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-E943F09A1F0A033EE2C13D03 | preparation-assessments-v3.8.json/19/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-4E4A985354D3435335B54818 | preparation-assessments-v3.8.json/19/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-6E2E5BF2A8794B499340F63D | preparation-assessments-v3.8.json/19/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-DE8EF985D6B2E1E86E68EC9F | preparation-assessments-v3.8.json/19/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-E1A09835CAB7D83AFD316DE1 | preparation-assessments-v3.8.json/19/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-199023E50693272780AB6E29 | preparation-assessments-v3.8.json/19/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-F17FB71CBAF022A70358FF0F | preparation-assessments-v3.8.json/19/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-56B8D34D59C3B81BE8BB87B4 | preparation-assessments-v3.8.json/19/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-D8F12CEDFFF8C7FCFC2C5039 | preparation-assessments-v3.8.json/19/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-C8F81046E61F6F12907A7624 | preparation-assessments-v3.8.json/19/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-F34DEEE44CB5B834721A86E9 | preparation-assessments-v3.8.json/19/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-72879E75D13090F040E70053 | preparation-assessments-v3.8.json/19/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-A8D7E8F8F008134D5946FC49 | preparation-assessments-v3.8.json/19/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-CF9013A510533FD757DAC2A0 | preparation-assessments-v3.8.json/19/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-27D807BCBD94424C00E8F1D2 | preparation-assessments-v3.8.json/19/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-67777EB6FFB899F5AF8F6F62 | preparation-assessments-v3.8.json/19/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-1CD110654DEFEE0AEA7F2C57 | preparation-assessments-v3.8.json/19/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-9BB0809CC4310EEC14763460 | preparation-assessments-v3.8.json/19/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-0B203C152EE3BBF57947F293 | preparation-assessments-v3.8.json/19/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-5E4FA8B9F19B60F0BBD17C61 | preparation-assessments-v3.8.json/19/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-D1AE1D127F73A9AA5AE3F2E2 | preparation-assessments-v3.8.json/19/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-FE4F8C420FE32912986811B3 | preparation-assessments-v3.8.json/19/population_applicability/adult/applicability | Historical; current review incomplete |
H51-0E33D6A24A91418617E048A9 | preparation-assessments-v3.8.json/19/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-7DC9C1648726EA8BFD99EFB5 | preparation-assessments-v3.8.json/19/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-DA01AF71988030DF65029F18 | preparation-assessments-v3.8.json/19/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-FBFE8F0194C3A0330EACFF54 | preparation-assessments-v3.8.json/19/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-93809DEDB86714E84C8821FD | preparation-assessments-v3.8.json/19/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-9291A2254F82BD4189D6D66C | preparation-assessments-v3.8.json/19/route_presence/structured_dilution | Historical; current review incomplete |
H51-EE151CB4C2685E038E4C4226 | preparation-assessments-v3.8.json/19/route_presence/iv_push | Historical; current review incomplete |
H51-CAEAECFBD406435949758E7D | preparation-assessments-v3.8.json/19/route_presence/continuous_infusion | Historical; current review incomplete |
H51-C7055CC4452635DAD7C9F10E | preparation-assessments-v3.8.json/19/route_presence/pediatric_source | Historical; current review incomplete |
H51-DF8C5E8B0A6B9DED32930207 | preparation-assessments-v3.8.json/19/route_presence/neonatal_source | Historical; current review incomplete |
H51-D88E7D00DAFDB162C5B6653D | preparation-assessments-v3.8.json/19/legacy_reference/status | Historical; current review incomplete |
H51-08FDDE5498D2820C54EF65DB | preparation-assessments-v3.8.json/19/label_resolution/status | Historical; current review incomplete |
H51-3F20E5C33D4814BED26265E9 | preparation-assessments-v3.8.json/19/source_files/0 | Historical; current review incomplete |
H51-6911C463AFC5E534653D2477 | preparation-assessments-v3.8.json/19/source_files/1 | Historical; current review incomplete |
H51-DEFFE50BDCA1405B2340B497 | preparation-assessments-v3.8.json/19/source_files/2 | Historical; current review incomplete |
H51-993DC7F2F006C69B8A37A0B2 | preparation-assessments-v3.8.json/19/clinical_release_note | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)